299
Participants
Start Date
November 9, 2006
Primary Completion Date
September 5, 2007
Study Completion Date
September 5, 2007
GW876008
paroxetine
GSK Investigational Site, Sandvika
GSK Investigational Site, Hamar
GSK Investigational Site, Durban
GSK Investigational Site, Tygerberg
GSK Investigational Site, Observatory ,Cape Town
GSK Investigational Site, New York
GSK Investigational Site, Berlin
GSK Investigational Site, Media
GSK Investigational Site, Turku
GSK Investigational Site, Rockville
GSK Investigational Site, Rauma
GSK Investigational Site, Westerstede
GSK Investigational Site, Achim
GSK Investigational Site, Smyrna
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, Hüttenberg
GSK Investigational Site, Göttingen
GSK Investigational Site, Farmington Hills
GSK Investigational Site, Oakbrook Terrace
GSK Investigational Site, Kuopio
GSK Investigational Site, Beverly Hills
GSK Investigational Site, Burbank
GSK Investigational Site, Temecula
GSK Investigational Site, Nutley
GSK Investigational Site, Edmonton
GSK Investigational Site, Kelowna
GSK Investigational Site, Miramichi
GSK Investigational Site, Mississauga
GSK Investigational Site, Oslo
GSK Investigational Site, Gothenburg
GSK Investigational Site, Malmo
GSK Investigational Site, Uppsala
Lead Sponsor
GlaxoSmithKline
INDUSTRY